Toggle Nav
$2,590.00

LNCaP SMAD/TGFbeta Reporter (Luc) stable cell line

Catalog number
CL-1469
Description
LNCaP SMAD/TGFbeta Reporter (Luc) cells are derived from the human prostate cancer LNCaP cell line by stably integration of a SMAD/TGFbeta firefly luciferase reporter construct. LNCaP cells are androgen-sensitive, making them valuable for studying prostate cancer biology and testing potential treatments related to hormone regulation. LNCaP SMAD/TGFbeta Reporter (Luc) cells stably express firefly luciferase under the control of the SMAD/TGFbeta response elements, can be used for monitoring the activity of TGFβ/SMAD signaling pathway.
LNCaP SMAD/TGFbeta Reporter (Luc) stable cell line
Product Details

Product Details

Package Size 2 x 10^6 cells
Parental cell line LNCaP cells
Transgenic gene Firefly luciferase
Mammalian selection Puromycin
Biosafety level 2
Storage Liquid nitrogen
Availability 3-4 weeks
Shipping condition dry ice

Premade Stable Cell Lines

  1. GFP-Firefly luciferase control cell lines
  2. RFP-Firefly luciferase control cell lines
  3. Fluorescent control cell lines
  4. Firefly luciferase control cell lines
  5. Signaling pathway reporter cell lines
  6. Cre stable cell lines
Copyright © 2024, FenicsBIO. All rights reserved.